Анотація
В оглядовій статті підсумовуються можливості використання антиконвульсанту габапентину (Медітану) в клінічній практиці при різноманітних захворюваннях як центральної, так і периферичної нервової системи з позиції доказової медицини та останніх рекомендацій Європейської федерації неврологічних товариств (EFNS), Британського Національного інституту здоров’я і клінічної кваліфікації (NICE), Американської академії неврології (AAN) і окремих провідних асоціацій і товариств.
Посилання
1. Маликова Л.А. Влияние леветирацетама на содержание медиаторных аминокислот в структурах мозга крыс при аудиогенном
эпилептиформном припадке / Л.А. Маликова, И.Б. Федотова, П.М. Клодт // Психофармакол. Биол. Наркол. - 2008. - Т. 8, № 3-4. - С. 2448-
2452.
2. Кукушкин М.Л. Неврогенная (невропатическая) боль / М.Л. Кукушкин // Лекарственный вестник. - 2006. - № 6. - C. 61-64.
3. American Epilepsy Society Subcommittee of the American Academy of Neurology and the Technology Assessment Subcommittee and Quality
Standards Treatment of new onset epilepsy: Report of the Therapeutics and Efficacy and tolerability of the new antiepileptic drugs I / J.A. French,
A.M. Kanner, J. Bautista [et al.] // Neurology. - 2004. - Vol. 62. - P. 1252-1260.
4. American Epilepsy Society Subcommittee of the American Academy of Neurology and the Technology Assessment Subcommittee and Quality
Standards Treatment of new onset epilepsy: Report of the Therapeutics and Efficacy and tolerability of the new antiepileptic drugs II / J.A. French,
A.M. Kanner, J. Bautista [et al.] // Neurology. - 2004. - Vol. 62. - P. 1261-1273.
5. A Randomized Study of the Effects of Single-dose Gabapentin versus Placebo on Postoperative Pain and Morphine Consumption after Mastectomy /
J. Dirks, B.B. Fredensborg, D. Christensen [et al.] // Anesthesiology. - 2002. - Vol. 97. - P. 560 - 564.
6. Coetzer R. Postherpetic neuralgia / R. Coetzer // S. Afr. Pharm. J. - 2011. - P. 78. - P. 36-39.
7. Complex Regional Pain Syndrome: Practical Diagnostic and Treatment Guidelines, 4th Edition / R.N. Harden, A.L. Oaklander, A.W. Burton, [et al.] //
Pain Medicine. - 2013. - P. 50.
8. Diagnosis and Treatment of Low Back Pain: A Joint Clinical Practice Guideline from the American College of Physicians and the American Pain Society
/ R. Chou, A. Qaseem, V. Snow, [et al.] // Ann. Intern. Med. - 2007. - Vol. 147. - P. 478-491.
9. EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision / N. Attal, G. Cruccu, R. Baron, [et al.] // European Journal of
Neurology. - 2010. - Vol. 17. - P. 1113-1123.
10. EFNS guideline on the drug treatment of migraine - revised report of an EFNS task force / S. Evers, J. Afra, A. Frese, [et al.] // European Journal of
Neurology. - 2009. - Vol. 16. - P. 968-981.
11. Evidence-based guideline update: Treatment of essential tremor: Report of the Quality Standards Subcommittee of the American Academy of
Neurology / T.A. Zesiewicz, R.J. Elble, E.D. Louis [et al.] // Neurology. - 2011. - Vol. 77. - P. 1752-1755.
12. Evidence-based guidelines for the pharmacological treatment of anxiety disorders: recommendations from the British Association for
Psychopharmacology / D.S. Baldwin, I.M. Anderson, D.J. Nutt, [et al.] // Psychopharm. Journal of Psychopharmacology. - 2005. - Vol. 19. - P. 567-596.
13. Evidence-based guideline: Treatment of painful diabetic neuropathy: Report of the American Academy of Neurology, the American Association of
Neuromuscular and Electrodiagnostic Medicine, and the American Academy of Physical Medicine and Rehabilitation / V. Bril, J. England, G.M. Franklin
[et al.] // Neurology. - 2011. - Vol. 76. - P. 1758-1765.
14. FDA approves Horizant to treat restless legs syndrome / FDA NEWS, 07.04.2011// http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/
ucm250188.htm.
15. Gabapentin premedication: assessment of preoperative anxiolysis and postoperative patient satisfaction / M. Tirault, L. Foucan, B. Debaene [et al.]
// Acta Anaesth. Belg. - 2010. - Vol. 61. - P. 203-209.
эпилептиформном припадке / Л.А. Маликова, И.Б. Федотова, П.М. Клодт // Психофармакол. Биол. Наркол. - 2008. - Т. 8, № 3-4. - С. 2448-
2452.
2. Кукушкин М.Л. Неврогенная (невропатическая) боль / М.Л. Кукушкин // Лекарственный вестник. - 2006. - № 6. - C. 61-64.
3. American Epilepsy Society Subcommittee of the American Academy of Neurology and the Technology Assessment Subcommittee and Quality
Standards Treatment of new onset epilepsy: Report of the Therapeutics and Efficacy and tolerability of the new antiepileptic drugs I / J.A. French,
A.M. Kanner, J. Bautista [et al.] // Neurology. - 2004. - Vol. 62. - P. 1252-1260.
4. American Epilepsy Society Subcommittee of the American Academy of Neurology and the Technology Assessment Subcommittee and Quality
Standards Treatment of new onset epilepsy: Report of the Therapeutics and Efficacy and tolerability of the new antiepileptic drugs II / J.A. French,
A.M. Kanner, J. Bautista [et al.] // Neurology. - 2004. - Vol. 62. - P. 1261-1273.
5. A Randomized Study of the Effects of Single-dose Gabapentin versus Placebo on Postoperative Pain and Morphine Consumption after Mastectomy /
J. Dirks, B.B. Fredensborg, D. Christensen [et al.] // Anesthesiology. - 2002. - Vol. 97. - P. 560 - 564.
6. Coetzer R. Postherpetic neuralgia / R. Coetzer // S. Afr. Pharm. J. - 2011. - P. 78. - P. 36-39.
7. Complex Regional Pain Syndrome: Practical Diagnostic and Treatment Guidelines, 4th Edition / R.N. Harden, A.L. Oaklander, A.W. Burton, [et al.] //
Pain Medicine. - 2013. - P. 50.
8. Diagnosis and Treatment of Low Back Pain: A Joint Clinical Practice Guideline from the American College of Physicians and the American Pain Society
/ R. Chou, A. Qaseem, V. Snow, [et al.] // Ann. Intern. Med. - 2007. - Vol. 147. - P. 478-491.
9. EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision / N. Attal, G. Cruccu, R. Baron, [et al.] // European Journal of
Neurology. - 2010. - Vol. 17. - P. 1113-1123.
10. EFNS guideline on the drug treatment of migraine - revised report of an EFNS task force / S. Evers, J. Afra, A. Frese, [et al.] // European Journal of
Neurology. - 2009. - Vol. 16. - P. 968-981.
11. Evidence-based guideline update: Treatment of essential tremor: Report of the Quality Standards Subcommittee of the American Academy of
Neurology / T.A. Zesiewicz, R.J. Elble, E.D. Louis [et al.] // Neurology. - 2011. - Vol. 77. - P. 1752-1755.
12. Evidence-based guidelines for the pharmacological treatment of anxiety disorders: recommendations from the British Association for
Psychopharmacology / D.S. Baldwin, I.M. Anderson, D.J. Nutt, [et al.] // Psychopharm. Journal of Psychopharmacology. - 2005. - Vol. 19. - P. 567-596.
13. Evidence-based guideline: Treatment of painful diabetic neuropathy: Report of the American Academy of Neurology, the American Association of
Neuromuscular and Electrodiagnostic Medicine, and the American Academy of Physical Medicine and Rehabilitation / V. Bril, J. England, G.M. Franklin
[et al.] // Neurology. - 2011. - Vol. 76. - P. 1758-1765.
14. FDA approves Horizant to treat restless legs syndrome / FDA NEWS, 07.04.2011// http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/
ucm250188.htm.
15. Gabapentin premedication: assessment of preoperative anxiolysis and postoperative patient satisfaction / M. Tirault, L. Foucan, B. Debaene [et al.]
// Acta Anaesth. Belg. - 2010. - Vol. 61. - P. 203-209.
Завантаження
Дані завантаження ще не доступні.